Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Jul 22;10(7):e0129545.
doi: 10.1371/journal.pone.0129545. eCollection 2015.

A Cluster Randomised Trial Introducing Rapid Diagnostic Tests into Registered Drug Shops in Uganda: Impact on Appropriate Treatment of Malaria

Anthony K Mbonye  1 , Pascal Magnussen  2 , Sham Lal  3 , Kristian S Hansen  4 , Bonnie Cundill  5 , Clare Chandler  4 , Siân E Clarke  3
Affiliations
Randomized Controlled Trial

A Cluster Randomised Trial Introducing Rapid Diagnostic Tests into Registered Drug Shops in Uganda: Impact on Appropriate Treatment of Malaria

Anthony K Mbonye et al. PLoS One. .

Abstract

Background: Inappropriate treatment of malaria is widely reported particularly in areas where there is poor access to health facilities and self-treatment of fevers with anti-malarial drugs bought in shops is the most common form of care-seeking. The main objective of the study was to examine the impact of introducing rapid diagnostic tests for malaria (mRDTs) in registered drug shops in Uganda, with the aim to increase appropriate treatment of malaria with artemisinin-based combination therapy (ACT) in patients seeking treatment for fever in drug shops.

Methods: A cluster-randomized trial of introducing mRDTs in registered drug shops was implemented in 20 geographical clusters of drug shops in Mukono district, central Uganda. Ten clusters were randomly allocated to the intervention (diagnostic confirmation of malaria by mRDT followed by ACT) and ten clusters to the control arm (presumptive treatment of fevers with ACT). Treatment decisions by providers were validated by microscopy on a reference blood slide collected at the time of consultation. The primary outcome was the proportion of febrile patients receiving appropriate treatment with ACT defined as: malaria patients with microscopically-confirmed presence of parasites in a peripheral blood smear receiving ACT or rectal artesunate, and patients with no malaria parasites not given ACT.

Findings: A total of 15,517 eligible patients (8672 intervention and 6845 control) received treatment for fever between January-December 2011. The proportion of febrile patients who received appropriate ACT treatment was 72·9% versus 33·7% in the control arm; a difference of 36·1% (95% CI: 21·3 - 50·9), p<0·001. The majority of patients with fever in the intervention arm accepted to purchase an mRDT (97·8%), of whom 58·5% tested mRDT-positive. Drug shop vendors adhered to the mRDT results, reducing over-treatment of malaria by 72·6% (95% CI: 46·7- 98·4), p<0·001) compared to drug shop vendors using presumptive diagnosis (control arm).

Conclusion: Diagnostic testing with mRDTs compared to presumptive treatment of fevers implemented in registered drug shops substantially improved appropriate treatment of malaria with ACT.

Trial registration: ClinicalTrials.gov NCT01194557.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Schematic diagram of the intervention design and treatment outcomes.
Fig 2
Fig 2. Trial profile appropriate treatment.
Fig 3
Fig 3. Trial profile provider adherence to mRDTs.
Fig 4
Fig 4. Number of consultations, malaria infection status and ACT treatment by month (Jan–Dec 2011).
Fig 5
Fig 5. Provider adherence by month (Jan–Dec 2011).
See this image and copyright information in PMC

References

    1. Ministry of Health. Health Sector Strategic Plan III. Ministry of Health, Box 7272, Kampala, Uganda; 2010.
    1. Ministry of Health, Kampala Uganda. Uganda Clinical Guidelines. Box 7272, Kampala, Uganda: Ministry of Health, 2010.
    1. Mbonye AK, Birungi J, Yanow S, Magnussen P. Prescription patterns and drug use among pregnant women with febrile Illnesses in Uganda: a survey in out-patient clinics. BMC Infect Dis 2013; 13(1):237. - PMC - PubMed
    1. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O, et al. (2004) Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 20: 329(7476):121. - PMC - PubMed
    1. Nankabirwa J, Zurovac D, Njogu JN, Rwakimari JB, Counihan H, Snow RW, et al. (2009) Malaria misdiagnosis in Uganda—implications for policy change. Malar J 8:66 10.1186/1475-2875-8-66 - DOI - PMC - PubMed

Publication types

Associated data